238 related articles for article (PubMed ID: 25746607)
1. Epstein-Barr virus viral load in human immunodeficiency virus-positive patients with reactive hemophagocytic syndrome.
Boisseau M; Lambotte O; Galicier L; Lerolle N; Marzac C; Aumont C; Coppo P; Fardet L
Infect Dis (Lond); 2015 Jun; 47(6):423-7. PubMed ID: 25746607
[TBL] [Abstract][Full Text] [Related]
2. Quantification of Epstein-Barr virus load in peripheral blood of human immunodeficiency virus-infected patients using real-time PCR.
Dehee A; Asselot C; Piolot T; Jacomet C; Rozenbaum W; Vidaud M; Garbarg-Chenon A; Nicolas JC
J Med Virol; 2001 Nov; 65(3):543-52. PubMed ID: 11596092
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus load and immune activation in human immunodeficiency virus type 1-infected patients.
Petrara MR; Cattelan AM; Zanchetta M; Sasset L; Freguja R; Gianesin K; Cecchetto MG; Carmona F; De Rossi A
J Clin Virol; 2012 Mar; 53(3):195-200. PubMed ID: 22209290
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr and cytomegalovirus DNA salivary shedding correlate with long-term plasma HIV RNA detection in HIV-infected men who have sex with men.
Scaggiante R; Andreis S; Basso M; Franchin E; Franzetti M; Del Vecchio C; Torti C; Mengoli C; Cruciani M; Sarmati L; Palù G; Parisi SG
J Med Virol; 2016 Jul; 88(7):1211-21. PubMed ID: 26636290
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults characterized by high viral genome load within circulating natural killer cells.
Fox CP; Shannon-Lowe C; Gothard P; Kishore B; Neilson J; O'Connor N; Rowe M
Clin Infect Dis; 2010 Jul; 51(1):66-9. PubMed ID: 20504238
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and risk factors for oral DNA tumor viruses in HIV-infected youth.
Kahn JA; Rudy BJ; Xu J; Kapogiannis B; Secord E; Gillison M
J Med Virol; 2016 Nov; 88(11):1944-52. PubMed ID: 27096166
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART.
O'Sullivan CE; Peng R; Cole KS; Montelaro RC; Sturgeon T; Jenson HB; Ling PD
J Med Virol; 2002 Jul; 67(3):320-6. PubMed ID: 12116021
[TBL] [Abstract][Full Text] [Related]
8. Lymphoma and Epstein-Barr virus DNA in blood during interleukin-2 therapy in antiretroviral-naïve HIV-1-infected patients: a substudy of the ANRS 119 trial.
de Lastours V; LeGoff J; Brière J; Agbalika F; Boulet T; Lévy Y; Simon F; Aboulker JP; Molina JM
HIV Med; 2014 Jan; 15(1):23-9. PubMed ID: 24007426
[TBL] [Abstract][Full Text] [Related]
9. Impact of Epstein-Barr virus load, virus genotype, and frequency of the 30 bp deletion in the viral BNLF-1 gene in patients harboring the human immunodeficiency virus.
Giron LB; Ramos da Silva S; Barbosa AN; Monteiro de Barros Almeida RA; Rosário de Souza Ld; Elgui de Oliveira D
J Med Virol; 2013 Dec; 85(12):2110-8. PubMed ID: 24014234
[TBL] [Abstract][Full Text] [Related]
10. A longitudinal and prospective study of Epstein-Barr virus load in AIDS-related non-Hodgkin lymphoma.
Bonnet F; Jouvencel AC; Parrens M; Leon MJ; Cotto E; Garrigue I; Morlat P; Beylot J; Fleury H; Lafon ME
J Clin Virol; 2006 Aug; 36(4):258-63. PubMed ID: 16762591
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus DNA loads in adult human immunodeficiency virus type 1-infected patients receiving highly active antiretroviral therapy.
Ling PD; Vilchez RA; Keitel WA; Poston DG; Peng RS; White ZS; Visnegarwala F; Lewis DE; Butel JS
Clin Infect Dis; 2003 Nov; 37(9):1244-9. PubMed ID: 14557970
[TBL] [Abstract][Full Text] [Related]
12. Dual Threat of Epstein-Barr Virus: an Autopsy Case Report of HIV-Positive Plasmablastic Lymphoma Complicating EBV-Associated Hemophagocytic Lymphohistiocytosis.
Koizumi Y; Imadome KI; Ota Y; Minamiguchi H; Kodama Y; Watanabe D; Mikamo H; Uehira T; Okada S; Shirasaka T
J Clin Immunol; 2018 May; 38(4):478-483. PubMed ID: 29687211
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for pediatric human immunodeficiency virus-related malignancy.
Pollock BH; Jenson HB; Leach CT; McClain KL; Hutchison RE; Garzarella L; Joshi VV; Parmley RT; Murphy SB
JAMA; 2003 May; 289(18):2393-9. PubMed ID: 12746363
[TBL] [Abstract][Full Text] [Related]
14. Early impairment of CD8+ T cells immune response against Epstein-Barr virus (EBV) antigens associated with high level of circulating mononuclear EBV DNA load in HIV infection.
Legoff J; Amiel C; Calisonni O; Fromentin D; Rajoely B; Abuaf N; Tartour E; Rozenbaum W; Bélec L; Nicolas JC
J Clin Immunol; 2004 Mar; 24(2):125-34. PubMed ID: 15024179
[TBL] [Abstract][Full Text] [Related]
15. Close relationship between immunoglobulin secreting-cells and Epstein-Barr virus reservoir in patients infected with HIV.
Ouedraogo DE; Tuaillon E; Rubbo PA; Bollore K; Foulongne V; Reynes J; Vendrell JP
J Med Virol; 2014 Jan; 86(1):30-7. PubMed ID: 24114930
[TBL] [Abstract][Full Text] [Related]
16. Infection of T lymphocytes in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children of non-Asian origin.
Beutel K; Gross-Wieltsch U; Wiesel T; Stadt UZ; Janka G; Wagner HJ
Pediatr Blood Cancer; 2009 Aug; 53(2):184-90. PubMed ID: 19353621
[TBL] [Abstract][Full Text] [Related]
17. Significance of Epstein-Barr virus (HHV-4) and CMV (HHV-5) infection among subtype-C human immunodeficiency virus-infected individuals.
Sachithanandham J; Kannangai R; Pulimood SA; Desai A; Abraham AM; Abraham OC; Ravi V; Samuel P; Sridharan G
Indian J Med Microbiol; 2014; 32(3):261-9. PubMed ID: 25008818
[TBL] [Abstract][Full Text] [Related]
18. Host-Epstein-Barr virus relationship affected by immunostimulation in HIV-infected patients representing distinct progressor profile groups.
Friis AM; Åkerlund B; Gyllensten K; Aleman A; Ernberg I
Scand J Infect Dis; 2012 May; 44(5):388-92. PubMed ID: 22243136
[TBL] [Abstract][Full Text] [Related]
19. A Rapid Cytologic Double Staining of Epstein-Barr Virus-encoded Small RNA and Cell Surface Markers for Diagnosis of Epstein-Barr Virus-associated Hemophagocytic Lymphohistiocytosis.
Takahashi N; Kudo K; Tanaka M; Kumagai N; Sato T; Kamio T; Sasaki S; Terui K; Kurose A; Yanagisawa R; Nakazawa Y; Ito E
J Pediatr Hematol Oncol; 2020 Nov; 42(8):e756-e758. PubMed ID: 31743316
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus load in children infected with human immunodeficiency virus type 1 in Uganda.
Petrara MR; Penazzato M; Massavon W; Nabachwa S; Nannyonga M; Mazza A; Gianesin K; Del Bianco P; Lundin R; Sumpter C; Zanchetta M; Giaquinto C; De Rossi A
J Infect Dis; 2014 Aug; 210(3):392-9. PubMed ID: 24550442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
